接种23价肺炎球菌多糖疫苗预防慢性阻塞性肺疾病急性发作的经济成本效益分析
접충23개폐염구균다당역묘예방만성조새성폐질병급성발작적경제성본효익분석
Cost-benefit analysis on use 23-valent pneumococcal polysaccharide vaccine in patients with COPD in acute stage
저자의 최근 논문